KeyBanc analyst Aleksey Yefremov lowered the firm’s price target on Entegris (ENTG) to $141 from $150 and keeps an Overweight rating on the ...

Deutsche Bank raised the firm’s price target on Entegris (ENTG) to $125 from $115 and keeps a Buy rating on the shares. The company’s Q4 ...

It's been a good week for Entegris, Inc. (NASDAQ:ENTG) shareholders, because the company has just released its latest annual results, and the shares gained 4.9% to US$107. Revenues were US$3.2b ...

Entegris reported sales of $849.84 million, marking a 5% growth year-over-year and quashing the analyst consensus estimate of $823.12 million. Segments: Materials Solutions revenue declined 1.1% ...

The report "Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile ...

You can find reconciliation tables in today's news release as well as on the IR page of our website at entegris.com. As we referenced in last quarter's call, we have combined our MC and AMH division.

Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast ...

In this article, we are going to take a look at where Entegris, Inc. (NASDAQ:ENTG) stands against the other chip stocks. The semiconductor industry is on a trajectory of rapid growth, with global ...

Investing.com - Entegris, Inc. (NASDAQ:ENTG) reported fourth-quarter 2024 results that exceeded analyst expectations, but provided first-quarter 2025 guidance below consensus estimates. The ...